Kidney International (1989) 36, 696–701; doi:10.1038/ki.1989.248
Reduced angiotensin receptors and pressor responses in hypotensive hemodialysis patients
Thomas J Moore1, J Michael Lazarus1, Raymond M Hakim1,1, with the technical assistance of Judy Newell1 and Amelia Nunn1
1Endocrine-Hypertension Division and Nephrology Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
Correspondence: Thomas J Moore MD, Endocrinology-Hypertension Division, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue, Boston, Massachusetts 02115, USA.
1Current address is Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
Received 17 November 1988; Revised 27 March 1989; Accepted 8 May 1989.
Top of pageAbstract
Reduced angiotensin receptors and pressor responses in hypotensive hemodialysis patients. A sub-set of patients on chronic hemodialysis develop sustained hypotension (systolic pressure < 100 mm Hg). To determine whether this hypotension could be due to altered production of, or sensitivity to angiotensin II (AH), we measured plasma renin (PRA), AII, and aldosterone in nine hypotensive and nine normotensive dialysis patients; we also assessed their sensitivity to infused AII and studied AII binding to their platelets as an indicator of AII receptors on vascular smooth muscle. All studies were performed just before dialysis when subjects were relatively volume-expanded. Hypotensives had higher PRA (5.7
2.4 vs. 2.1
0.8 ng AI/ml/hr, P < 0.05), AII (56
15 vs. 31
3 pg/ml), and aldosterone (91
35 vs. 21
7 ng/dl, P < 0.05) than did normotensives. During AII infusion at 1, 3, 10, and 30 ng/kg/min for 15 minutes each, hypotensives displayed a significantly blunted pressor effect across the range of AII doses. In parallel with this, hypotensives showed reduced AII receptors on their platelets compared to normotensives (0.8
0.4 vs. 3.6
1.0% 125I-AII specifically bound; P < 0.03). Binding analysis revealed a single affinity state for the AII receptors which was similar in both groups (Kd = 3.2
1.1 for hypotensives vs. 3.8
0.7
10-10 M for normotensives). The two groups had similar levels of plasma catecholamines, similar slowing of heart rate during AII infusion and no postural hypotension, indicating intact sympathetic nervous system pathways. Thus, hypotensive dialysis patients display both a reduced pressor response to infused AII and reduced AII receptors on their platelets. This defective AII responsiveness may contribute to the hypotension in these patients.
Top of pageReferences
- Hollenberg NK, Chenitz WR, Adams DF, Williams GH: Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 54:34–42, 1974 | PubMed | ISI | ChemPort |
- Shoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hollenberg NK: Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest 72:2115–2124, 1983 | PubMed | ISI | ChemPort |
- Gunther S, Gimbrone MA, Alexander RW: Identification and characterization of the high affinity vascular angiotensin II receptor in rat mesenteric artery. Circ Res 47:278–286, 1980
- Gunther S, Gimbrone MA, Alexander RW: Regulation by angiotensin II of its receptors in resistance blood vessels. Nature 287:230–232, 1980 | Article |
- Moore TJ, Williams GH: Angiotensin II receptors on human platelets. Circ Res 51:314–320, 1982
- Moore TJ, Taylor T, Williams GH: Human platelet angiotensin II receptors: Regulation by the circulating angiotensin level. J Clin Endocrinol Metab 58:778–782, 1984
- Skorecki KL, Ballerman BJ, Rennke HG, Brenner BM: Angiotensin II receptor regulation in isolated renal glomeruli. Fed Proc 42:3064–3070, 1983 | PubMed | ISI | ChemPort |
- Gambhir KK, Archer JA, Bradley CJ: Characteristics of human erythrocyte insulin receptors. Diabetes 27:701–708, 1978 | PubMed | ISI | ChemPort |
- Munson PJ, Rodbard D: Computerized analysis of ligand binding data: Basic principles and recent developments, in Computers in Endocrinology, edited by Forti G, Rodbard D, New York, Raven Press, 1984, pp. 117–145
- Emmanuel RL, Cain JP, Williams GH: Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med 81:632–640, 1973 | PubMed | ISI | ChemPort |
- Peuler JD, Johnson GA: Simultaneous single isotope radioenzy-matic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 21:625–636, 1977 | Article | PubMed | ISI | ChemPort |
- Ding YA, Kenyon CJ, Semple PF: Receptors for angiotensin II on platelets from man. Clin Sci 66:725–731, 1984
- Ding YA, Kenyon CJ, Semple PF: Regulation of platelet receptors for angiotensin II in man. J Hypert ens 3:209–212, 1985
- Nies AS, Robertson D, Stone WJ: Hemodialysis hypotension is not the result of uremic peripheral autonomic neuropathy. J Lab Clin Med 94:395–402, 1979 | PubMed | ISI | ChemPort |
- Imai Y, Abe K, Otsuka Y, Sato M, Haruyama T, Ito T, Omata K, Yoshinaga K, Sekino H: Blood pressure regulation in chronic hypotensive and hypertensive patients with chronic renal failure. Jap Circ J 45:303–314, 1981
- Daul AE, Wang XL, Michel MC, Brodde O-E: Arterial hypotension in chronic hemodialyzed patients. Kidney Int 32:728–735, 1987 | PubMed | ISI | ChemPort |
- Elias AN, Vaziri ND, Maksy M: Plasma norepinephrine, epinephrine, and dopamine levels in end-stage renal disease: Effect of hemodialysis. Arch Int Med 145:1013–1015, 1985
- Sorensen SS, Danielsen H, Jespersen B, Pedersen EB: Hypotension in end-stage renal disease: Effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone, and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis. Clin Nephrol 26:288–296, 1986
- Tajiri M, Aizawa Y, Sakai S, Imai K, Hirasawa Y: Vascular responsiveness and body fluid status in patients on chronic hemodialysis. J Dial 4:167–177, 1980